KURE : KraneShares MSCI All China Health Care Index ETF

KURE is a International Stocks Market China Stock with MODERATE fees.

KURE

KraneShares MSCI All China Health Care Index ETF

FI Score

53 /100

Diversification Rating

0 /10

Expense Ratio Rating

7 /10

Expense Rating

4 /10

Market Score

6 /10

Category Score

5 /10

Market Size

6 /10

53% FI Score
  • kure
  • ETF
  • International Stocks
  • China Stock

KraneShares MSCI All China Health Care Index ETF

Expenses: 0.65% (Better than 1% of similar funds)

This is an OK choice for a China Stock International Stocks fund. See why ยป

Fund Summary

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index (the underlying index). The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, including American depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The fund is non-diversified.

Largest Holdings

Amount Holding
8.25% Jiangsu Hengrui Medicine Co Ltd
5.74% WuXi Biologics Inc Registered Shs Unitary 144A/Reg S
5.73% Shenzhen Mindray Bio-Medical Electronics Co Ltd
5.02% Sino Biopharmaceutical Ltd
4.36% CSPC Pharmaceutical Group Ltd
3.76% Alibaba Health Information Technology Ltd
3.11% Wuxi AppTec Co Ltd Class A
3.07% Aier Eye Hospital Group Co Ltd
2.40% Innovent Biologics Inc
2.27% Yunnan Baiyao Group Co Ltd

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo